• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CONTRIBUTI SCIENTIFICI – Scientific Papers

Volume:

Biochimica Clinica 2015; 39(6) 575-584

Pubblicato on-line:

DOI:

Scarica in PDF:

Indagine sui metodi di determinazione e sulle modalità di refertazione dell’attività catalitica degli enzimi nel siero

AUTORI

Giampaolo Cattozzo per il Gruppo di Studio SIBioC - Medicina di Laboratorio Enzimi Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi, Varese

ABSTRACT

Survey of analytical methods and result reporting for the measurement of catalytic activity of serum enzymes

The method-dependent variability of results of enzyme assays hampers the use of common reference intervals and clinical decision thresholds.
Such a situation may confuse the understanding of patient results. Furthermore, the use of analytical results may be jeopardized by heterogeneity in terminology and units.
The aim of this study was to check the spread in Italian laboratories of different methods for measurement of alanine aminotransferase (ALT), total and pancreatic a-amylase, aspartate aminotransferase (AST), cholinesterase, creatine kinase (CK), alkaline phosphatase (ALP), g-glutamyltransferase (GGT), lactate dehydrogenase (LDH) and pancreatic lipase. 91%, 76%, 67%, 52%, 37% and 36% of laboratories adopted the relevant IFCC principle for CK, GGT, LDH, a-amylase, AST and ALT measurements, respectively.
80% of laboratories used aminometylpropanol-buffer methods for ALP assays, whereas butyrylthiocholine and 1,2-diglycerides were the most widely used substrates for cholinesterase and lipase assays.
The traceability of calibration was not always assured, although the IFCC analytical principles were used. All laboratories used the U/L unit, but differences in terminology, reference intervals and threshold limits were observed for all the surveyed enzymes.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967